Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?

BACKGROUND: With the recent publication of a large clinical trial on the use of a lower dose of intravenous (IV) tissue plasminogen activator (tPA) for acute ischaemic stroke (AIS), the concept of using a different dose has been debated. We intend to review the literature on using a lower dose of IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yi, Cao, Wenjie, Cheng, Xin, Fang, Kun, Wu, Fei, Yang, Lumeng, Xie, Yanan, Dong, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435201/
https://www.ncbi.nlm.nih.gov/pubmed/28959472
http://dx.doi.org/10.1136/svn-2016-000033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435201/
https://www.ncbi.nlm.nih.gov/pubmed/28959472
http://dx.doi.org/10.1136/svn-2016-000033

Ejemplares similares